第42届摩根大通医疗健康年会进行之时,礼来迎来了2025年第一场股价大跌。1月14日美股收盘,礼来股价下滑6.59%至744.91美元/股。由于其超高基数,市值一夜之间蒸发了500亿美元。礼来的股价下跌与其披露的2024年全年业绩预期有关。而礼来的业绩变化与肠促胰素(包括GLP-1药物)的预测偏差有关。礼来公司首席执行官David Ricks在业绩指引中表示,2024年第四季度,虽然美国肠促胰素...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.